articleTop 1% cited
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
Life Sciences · 1982 · Vol. 31(11) · pp. 1133–1140
Neuroendocrine Tumor Research AdvancesGrowth Hormone and Insulin-like Growth FactorsGlycosylation and Glycoproteins ResearchSomatostatinIn vivoIn vitroSecretionHormoneChemistryMoietyBiological activityPharmacologyMechanism of action
MeSH terms
AnimalsCells, CulturedDrug EvaluationFemaleHumansMacaca mulattaMalePituitary GlandRadioimmunoassaySomatostatinGrowth HormoneOctreotideRats
Citations
1,328
FWCI
16.01
field-weighted impact
References
7
Percentile
99%
vs. same field & year
Citations per year
Cited by
Peptidomimetics for Receptor Ligands—Discovery, Development, and Medical Perspectives
Angewandte Chemie International Edition in English · 1993 · 778 citations
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Endocrine Reviews · 2003 · 1,122 citations
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
Alimentary Pharmacology & Therapeutics · 2009 · 404 citations
Recent advances in tumor-targeting anticancer drug conjugates
Bioorganic & Medicinal Chemistry · 2005 · 490 citations
SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile
European Journal of Endocrinology · 2002 · 683 citations
Role of octreotide in the prevention of postoperative complications following pancreatic resection
The American Journal of Surgery · 1992 · 443 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.